{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:47:15Z","timestamp":1781840835762,"version":"3.54.5"},"reference-count":29,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000014","name":"Canadian Blood Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000014","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>West Nile Virus (WNV) is a member of the Japanese Encephalitis (JE) serocomplex within the <jats:italic>Flaviviridae<\/jats:italic> family. We report four whole blood donors and one plasma donor with WNV nucleic acid test (NAT)\u2010reactive donations between September 2018 and November 2019, following recent Japanese Encephalitis virus (JEV) vaccination.<\/jats:p><\/jats:sec><jats:sec><jats:title>CASE SERIES<\/jats:title><jats:p>Cases 1 and 4 had reactive WNV NAT donations 1 day after receiving the JEV vaccine. Case 2 had a reactive WNV donation 3\u2009days after receiving the JEV vaccine. Case 3 had a reactive WNV NAT donation 3\u2009days after returning from Arizona and 1 day after receiving the JEV vaccine. Case 5 had a reactive WNV donation the same day as receiving the JEV vaccine.<\/jats:p><\/jats:sec><jats:sec><jats:title>STUDY DESIGN AND METHODS<\/jats:title><jats:p>WNV screening used the Roche cobas WNV nucleic acid test (NAT) (Roche Molecular Systems). Reference testing on WNV\u2010reactive donations was carried out by the National Microbiology Laboratory (NML). JEV vaccine dilutions were also analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Supplemental NAT was negative for WNV and JEV for Cases 1, 3, and 5. Case 2 had a weak amplification curve for one of two JEV NAT targets. Case 4 was JEV NAT\u2010positive, WNV NAT\u2010negative. Serologic testing on donation specimens for Cases 2, 4, and 5 did not support recent or remote WNV infection. JEV vaccine dilutions were detected by both cobas and supplemental NAT.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>We recommend implementing a temporary blood donor deferral following a JEV vaccination, if screening utilizes a WNV assay with the capability of detecting other members of the JE serocomplex.<\/jats:p><\/jats:sec>","DOI":"10.1111\/trf.15744","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T12:58:19Z","timestamp":1583845099000},"page":"1097-1103","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A case series of inactivated Japanese encephalitis virus vaccination associated with positive <scp>West Nile<\/scp> virus blood donor screening nucleic acid tests"],"prefix":"10.1111","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2519-1109","authenticated-orcid":false,"given":"Steven J.","family":"Drews","sequence":"first","affiliation":[{"name":"Canadian Blood Services  Edmonton Alberta Canada"},{"name":"Laboratory Medicine and Pathology University of Alberta  Edmonton Alberta Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Makowski","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory  Winnipeg Manitoba Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Wood","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory  Winnipeg Manitoba Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Dimitrova","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory  Winnipeg Manitoba Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6404-1931","authenticated-orcid":false,"given":"Matthew T.S.","family":"Yan","sequence":"additional","affiliation":[{"name":"Canadian Blood Services  Vancouver British Columbia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Young","sequence":"additional","affiliation":[{"name":"Canadian Blood Services  Calgary Alberta Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Skeate","sequence":"additional","affiliation":[{"name":"Canadian Blood Services  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Ng","sequence":"additional","affiliation":[{"name":"Canadian Blood Services  Calgary Alberta Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Hawes","sequence":"additional","affiliation":[{"name":"Canadian Blood Services  Brampton Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Fearon","sequence":"additional","affiliation":[{"name":"Canadian Blood Services  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bigham","sequence":"additional","affiliation":[{"name":"Canadian Blood Services  Vancouver British Columbia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-005-0626-6"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.11.180"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15022"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02501-09"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20930"},{"key":"e_1_2_10_7_1","first-page":"214","volume-title":"CDC Yellow Book 2018","author":"Hills S","year":"2017"},{"key":"e_1_2_10_8_1","unstructured":"Assessment report for IXIARO. European Medicins Agency. 2019. Available from:https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/ixiaro-epar-public-assessment-report_en.pdf."},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.4161\/21645515.2014.983412"},{"issue":"1","key":"e_1_2_10_10_1","first-page":"E99","article-title":"Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO\u00ae)","volume":"59","author":"Amicizia D","year":"2018","journal-title":"J Prev Med Hyg"},{"key":"e_1_2_10_11_1","unstructured":"CobasWNVNAT for use on the cobas 6800\/8800 Systems (Roche Molecular Systems Pleasanton CA). Roche Molecular Systems.2019. Available from:https:\/\/www.fda.gov\/media\/134976\/download."},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194412"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.11.4066-4071.2000"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2006.03.009"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1002.030759"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197074"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.5.1823-1826.2000"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1958.7.561"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1086\/591467"},{"key":"e_1_2_10_20_1","unstructured":"Arizona Department of Health Services. Office of Infectious Disease Services. Arizona 2019 West Nile virus statistics. Government of Arizona. 2019. Available from:https:\/\/www.azdhs.gov\/documents\/preparedness\/epidemiology-disease-control\/mosquito-borne\/west-nile\/data\/west-nile-virus-az-2019.pdf."},{"key":"e_1_2_10_21_1","unstructured":"West Nile virus and surveillance. Alberta Health. 2019. Available from:https:\/\/www.alberta.ca\/west-nile-virus-surveillance.aspx#toc-1."},{"key":"e_1_2_10_22_1","unstructured":"Mosquito\u2010borne disease survillance report: September 29\u2010October 2019 (Weeks 40 & 41). Public Health Agency of Canada. 2019. Available from:https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/publications\/diseases-conditions\/west-nile-virus-surveillance\/2019\/week4041\/Report_Week41EN-up.pdf."},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jme\/tjw105"},{"key":"e_1_2_10_24_1","unstructured":"West Nile Virus surveilance. Government of Newfoundland and Labrador. 2010. Available fromhttps:\/\/www.faa.gov.nl.ca\/agrifoods\/animals\/health\/pdf\/ds_08_002.pdf."},{"key":"e_1_2_10_25_1","unstructured":"Weekly updates: 2019 West Nile virus transmission season. European Centre for Disease Prevention and Control. 2019. Available from:https:\/\/www.ecdc.europa.eu\/en\/west-nile-fever\/surveillance-and-disease-data\/disease-data-ecdc."},{"key":"e_1_2_10_26_1","unstructured":"West Nile Virus and Other Mosquito\u2010borne Disease Report Report October 21\u2013October 27 2018 (Report Week 43). [cited 2019 Jan 17]. Available from:https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/west-nile-virus-surveillance\/2018\/october-21-27-week-43.html."},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2401.171297"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.43.1800545"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15444"},{"key":"e_1_2_10_30_1","unstructured":"Canadian Blood Services. Canadian Blood Services Donor Selection Criteria Manual. Section U and V \u201cVaccinations.\u201d2020 Canadian Blood Services Ottawa ON."}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.15744","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.15744","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/trf.15744","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.15744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T08:32:38Z","timestamp":1693989158000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.15744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1111\/trf.15744"],"URL":"https:\/\/doi.org\/10.1111\/trf.15744","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]},"assertion":[{"value":"2019-09-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}